reference/26686555

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26686555

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	105
issn	0344-5704 1432-0843
issueIdentifier	2
pageRange	97-105
publicationName	Cancer Chemotherapy and Pharmacology
startingPage	97
bibliographicCitation	Nakanishi T, Hayakawa K, Matsuzawa A, Eriguchi M, Takeda Y, Kidani Y, Kizu R, Tashiro T, Akiyama N. A new orally active antitumor 1 R ,2 R -cyclohexanediamine-platinum(IV) complex: trans -( n -valerato)chloro(1 R ,2 R -cyclohexanediamine) (oxalato)platinum(IV). Cancer Chemotherapy and Pharmacology. 1999 Feb 01;43(2):97–105. doi: 10.1007/s002800050869.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d68c45691dab867603fb289ee4f8c01c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86071e44c2aff02abab178c664f02613 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6561-7138 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2fb1ab4667f03a45073ae45f2112cf7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_301bac89f0ac269c8f6a6b9dc044c834 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65ae87372f554564c0a91ba3f054e903 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_480199c13e4039a12b9e6a9849af8caa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c659a80367507ab17b546044a3684008 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab0c2a6be0ec6a13582841dcf2f2d319 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ca50d556df1682f816423146c582c7c1
date	1999-02-01^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/9923814 https://doi.org/10.1007/s002800050869
isPartOf	https://portal.issn.org/resource/ISSN/0344-5704 https://portal.issn.org/resource/ISSN/1432-0843 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2664
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A new orally active antitumor 1 R ,2 R -cyclohexanediamine-platinum(IV) complex: trans -( n -valerato)chloro(1 R ,2 R -cyclohexanediamine) (oxalato)platinum(IV)
discusses	http://id.nlm.nih.gov/mesh/M0274914 http://id.nlm.nih.gov/mesh/M0017642 http://id.nlm.nih.gov/mesh/M0015422 http://id.nlm.nih.gov/mesh/M0300466 http://id.nlm.nih.gov/mesh/M0300470 http://id.nlm.nih.gov/mesh/M0300468 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D011355Q000494 http://id.nlm.nih.gov/mesh/D009944Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D009944Q000493 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D008810 http://id.nlm.nih.gov/mesh/D008811 http://id.nlm.nih.gov/mesh/D016403Q000188 http://id.nlm.nih.gov/mesh/D011355Q000737 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D019540 http://id.nlm.nih.gov/mesh/D011355Q000493 http://id.nlm.nih.gov/mesh/D009944Q000737
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93052 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7991 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4398339 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129685811 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8892 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9887053 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8517 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57741935 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104775 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390

Showing number of triples: 1 to 70 of 70.